Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds

Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammad Hassan Baig, Arif Tasleem Jan, Gulam Rabbani, Khurshid Ahmad, Jalaluddin M. Ashraf, Taeyeon Kim, Han Sol Min, Yong Ho Lee, Won-Kyung Cho, Jin Yeul Ma, Eun Ju Lee, Inho Choi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/94173ec599664c7bb5c955481c28e941
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:94173ec599664c7bb5c955481c28e941
record_format dspace
spelling oai:doaj.org-article:94173ec599664c7bb5c955481c28e9412021-12-02T11:40:22ZMethylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds10.1038/s41598-017-06067-52045-2322https://doaj.org/article/94173ec599664c7bb5c955481c28e9412017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06067-5https://doaj.org/toc/2045-2322Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes, MG increased oxidative stress and reduced myotube formation in C2C12 cells. RAGE (receptor for AGEs) expression was up-regulated and MYOD and myogenin (MYOG) expressions were concomitantly down-regulated in MG-treated cells. Interestingly, AGE levels were higher in plasma (~32 fold) and muscle (~26 fold) of diabetic mice than in control mice. RAGE knock-down (RAGEkd) reduced the expressions of MYOD and MYOG and myotube formation in C2C12 cells. In silico studies of interactions between curcumin or gingerol and myostatin (MSTN; an inhibitor of myogenesis) and their observed affinities for activin receptor type IIB (ACVRIIB) suggested curcumin and gingerol reduce the interaction between MSTN and ACVRIIB. The findings of this study suggest enhanced AGE production and subsequent RAGE-AGE interaction obstruct the muscle development program, and that curcumin and gingerol attenuate the effect of AGEs on myoblasts.Mohammad Hassan BaigArif Tasleem JanGulam RabbaniKhurshid AhmadJalaluddin M. AshrafTaeyeon KimHan Sol MinYong Ho LeeWon-Kyung ChoJin Yeul MaEun Ju LeeInho ChoiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mohammad Hassan Baig
Arif Tasleem Jan
Gulam Rabbani
Khurshid Ahmad
Jalaluddin M. Ashraf
Taeyeon Kim
Han Sol Min
Yong Ho Lee
Won-Kyung Cho
Jin Yeul Ma
Eun Ju Lee
Inho Choi
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
description Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes, MG increased oxidative stress and reduced myotube formation in C2C12 cells. RAGE (receptor for AGEs) expression was up-regulated and MYOD and myogenin (MYOG) expressions were concomitantly down-regulated in MG-treated cells. Interestingly, AGE levels were higher in plasma (~32 fold) and muscle (~26 fold) of diabetic mice than in control mice. RAGE knock-down (RAGEkd) reduced the expressions of MYOD and MYOG and myotube formation in C2C12 cells. In silico studies of interactions between curcumin or gingerol and myostatin (MSTN; an inhibitor of myogenesis) and their observed affinities for activin receptor type IIB (ACVRIIB) suggested curcumin and gingerol reduce the interaction between MSTN and ACVRIIB. The findings of this study suggest enhanced AGE production and subsequent RAGE-AGE interaction obstruct the muscle development program, and that curcumin and gingerol attenuate the effect of AGEs on myoblasts.
format article
author Mohammad Hassan Baig
Arif Tasleem Jan
Gulam Rabbani
Khurshid Ahmad
Jalaluddin M. Ashraf
Taeyeon Kim
Han Sol Min
Yong Ho Lee
Won-Kyung Cho
Jin Yeul Ma
Eun Ju Lee
Inho Choi
author_facet Mohammad Hassan Baig
Arif Tasleem Jan
Gulam Rabbani
Khurshid Ahmad
Jalaluddin M. Ashraf
Taeyeon Kim
Han Sol Min
Yong Ho Lee
Won-Kyung Cho
Jin Yeul Ma
Eun Ju Lee
Inho Choi
author_sort Mohammad Hassan Baig
title Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
title_short Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
title_full Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
title_fullStr Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
title_full_unstemmed Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
title_sort methylglyoxal and advanced glycation end products: insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/94173ec599664c7bb5c955481c28e941
work_keys_str_mv AT mohammadhassanbaig methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT ariftasleemjan methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT gulamrabbani methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT khurshidahmad methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT jalaluddinmashraf methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT taeyeonkim methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT hansolmin methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT yongholee methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT wonkyungcho methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT jinyeulma methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT eunjulee methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
AT inhochoi methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds
_version_ 1718395659323703296